BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gil-Martín E, Egea J, Reiter RJ, Romero A. The emergence of melatonin in oncology: Focus on colorectal cancer.Med Res Rev. 2019;39:2239-2285. [PMID: 30950095 DOI: 10.1002/med.21582] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Gao T, Wang T, Wang Z, Cao J, Dong Y, Chen Y. Melatonin-mediated MT2 attenuates colitis induced by dextran sodium sulfate via PI3K/AKT/Nrf2/SIRT1/RORα/NF-κB signaling pathways. Int Immunopharmacol 2021;96:107779. [PMID: 34162146 DOI: 10.1016/j.intimp.2021.107779] [Reference Citation Analysis]
2 Liu J, Zhong Y, Luo XM, Ma Y, Liu J, Wang H. Intermittent Fasting Reshapes the Gut Microbiota and Metabolome and Reduces Weight Gain More Effectively Than Melatonin in Mice. Front Nutr 2021;8:784681. [PMID: 34901130 DOI: 10.3389/fnut.2021.784681] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang N, Sundquist J, Sundquist K, Ji J. Use of Melatonin Is Associated With Lower Risk of Colorectal Cancer in Older Adults. Clin Transl Gastroenterol 2021;12:e00396. [PMID: 34342302 DOI: 10.14309/ctg.0000000000000396] [Reference Citation Analysis]
4 Reiter RJ, Sharma R, Rodriguez C, Martin V, Rosales-Corral S, Zuccari DAPC, Chuffa LGA. Part-time cancers and role of melatonin in determining their metabolic phenotype. Life Sci 2021;278:119597. [PMID: 33974932 DOI: 10.1016/j.lfs.2021.119597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Hesse J, Martinelli J, Aboumanify O, Ballesta A, Relógio A. A mathematical model of the circadian clock and drug pharmacology to optimize irinotecan administration timing in colorectal cancer. Comput Struct Biotechnol J 2021;19:5170-83. [PMID: 34630937 DOI: 10.1016/j.csbj.2021.08.051] [Reference Citation Analysis]
6 Sharda N, Ikuse T, Hill E, Garcia S, Czinn SJ, Bafford A, Blanchard TG, Banerjee A. Impact of Andrographolide and Melatonin Combinatorial Drug Therapy on Metastatic Colon Cancer Cells and Organoids. Clin Med Insights Oncol 2021;15:11795549211012672. [PMID: 34158803 DOI: 10.1177/11795549211012672] [Reference Citation Analysis]
7 Banerjee V, Sharda N, Huse J, Singh D, Sokolov D, Czinn SJ, Blanchard TG, Banerjee A. Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method. Eur J Pharmacol 2021;897:173919. [PMID: 33577837 DOI: 10.1016/j.ejphar.2021.173919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Phiboonchaiyanan PP, Puthongking P, Chawjarean V, Harikarnpakdee S, Sukprasansap M, Chanvorachote P, Priprem A, Govitrapong P. Melatonin and its derivative disrupt cancer stem-like phenotypes of lung cancer cells via AKT downregulation. Clin Exp Pharmacol Physiol 2021. [PMID: 34396568 DOI: 10.1111/1440-1681.13572] [Reference Citation Analysis]
9 Bai Y, Guo J, Reiter RJ, Wei Y, Shi H. Melatonin synthesis enzymes interact with ascorbate peroxidase to protect against oxidative stress in cassava. J Exp Bot 2020;71:5645-55. [PMID: 32474586 DOI: 10.1093/jxb/eraa267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
10 Reiter RJ, Sharma R, Ma Q, Rorsales-Corral S, de Almeida Chuffa LG. Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis. Cell Mol Life Sci 2020;77:2527-42. [PMID: 31970423 DOI: 10.1007/s00018-019-03438-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
11 Marhuenda J, Villaño D, Arcusa R, Zafrilla P. Melatonin in Wine and Beer: Beneficial Effects. Molecules 2021;26:E343. [PMID: 33440795 DOI: 10.3390/molecules26020343] [Reference Citation Analysis]
12 Socaciu AI, Ionuţ R, Socaciu MA, Ungur AP, Bârsan M, Chiorean A, Socaciu C, Râjnoveanu AG. Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases. Rev Endocr Metab Disord 2020;21:465-78. [PMID: 32691289 DOI: 10.1007/s11154-020-09570-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
13 Pan S, Guo Y, Hong F, Xu P, Zhai Y. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota. Biochim Biophys Acta Mol Basis Dis 2022;1868:166281. [PMID: 34610472 DOI: 10.1016/j.bbadis.2021.166281] [Reference Citation Analysis]
14 Farré-Alins V, Narros-Fernández P, Palomino-Antolín A, Decouty-Pérez C, Lopez-Rodriguez AB, Parada E, Muñoz-Montero A, Gómez-Rangel V, López-Muñoz F, Ramos E, González-Rodríguez Á, Gandía L, Romero A, Egea J. Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux. Antioxidants (Basel) 2020;9:E1299. [PMID: 33353046 DOI: 10.3390/antiox9121299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Gil-Martín E, López-Muñoz F, Reiter RJ, Romero A. Understanding the oncostatic actions displayed by melatonin in colorectal cancer therapy. Future Med Chem 2020;12:1201-4. [PMID: 32466682 DOI: 10.4155/fmc-2020-0086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Huh E, Gallion J, Agosto MA, Wright SJ, Wensel TG, Lichtarge O. Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors. Proc Natl Acad Sci U S A 2021;118:e2113373118. [PMID: 34916293 DOI: 10.1073/pnas.2113373118] [Reference Citation Analysis]
17 Haynes T, Oprea-Ilies G, Manne U, Singh R, Singh S, Mir H. The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity. Transl Oncol 2022;16:101330. [PMID: 34990909 DOI: 10.1016/j.tranon.2021.101330] [Reference Citation Analysis]
18 Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules 2021;26:2506. [PMID: 33923028 DOI: 10.3390/molecules26092506] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
19 Egea J, López-Muñoz F, Fernández-Capetillo O, Reiter RJ, Romero A. Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies. Front Pharmacol 2022;13:873197. [PMID: 35401215 DOI: 10.3389/fphar.2022.873197] [Reference Citation Analysis]
20 Mihanfar A, Yousefi B, Ghazizadeh Darband S, Sadighparvar S, Kaviani M, Majidinia M. Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP. Bioimpacts 2021;11:253-61. [PMID: 34631487 DOI: 10.34172/bi.2021.36] [Reference Citation Analysis]
21 Ma N, Zhang J, Reiter RJ, Ma X. Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation. Med Res Rev 2020;40:606-32. [PMID: 31420885 DOI: 10.1002/med.21628] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
22 Lu KH, Lin CW, Hsieh YH, Su SC, Reiter RJ, Yang SF. New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence. Cancer Metastasis Rev 2020;39:303-20. [PMID: 32086631 DOI: 10.1007/s10555-020-09845-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
23 Prašnikar E, Borišek J, Perdih A. Senescent cells as promising targets to tackle age-related diseases. Ageing Res Rev 2021;66:101251. [PMID: 33385543 DOI: 10.1016/j.arr.2020.101251] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
24 Mirza-Aghazadeh-Attari M, Mohammadzadeh A, Mostavafi S, Mihanfar A, Ghazizadeh S, Sadighparvar S, Gholamzadeh S, Majidinia M, Yousefi B. Melatonin: An important anticancer agent in colorectal cancer. J Cell Physiol 2020;235:804-17. [PMID: 31276205 DOI: 10.1002/jcp.29049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
25 Capote-Moreno A, Ramos E, Egea J, López-Muñoz F, Gil-Martín E, Romero A. Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics. Cancers (Basel) 2019;11:E1712. [PMID: 31684096 DOI: 10.3390/cancers11111712] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
26 Wang C, Zhao Z, Qi Q, Wang J, Kong Y, Feng Z, Chen A, Li W, Zhang Q, Wang J, Huang B, Li X. miR-6858 plays a key role in the process of melatonin inhibition of the malignant biological behavior of glioma. J Clin Neurosci 2021;87:137-46. [PMID: 33863521 DOI: 10.1016/j.jocn.2021.02.015] [Reference Citation Analysis]
27 Li M, Hao B, Zhang M, Reiter RJ, Lin S, Zheng T, Chen X, Ren Y, Yue L, Abay B, Chen G, Xu X, Shi Y, Fan L. Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development. Signal Transduct Target Ther 2021;6:330. [PMID: 34471091 DOI: 10.1038/s41392-021-00745-7] [Reference Citation Analysis]
28 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2022;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
29 Lee CC, Kuo YC, Hu JM, Chang PK, Sun CA, Yang T, Li CW, Chen CY, Lin FH, Hsu CH, Chou YC. MTNR1B polymorphisms with CDKN2A and MGMT methylation status are associated with poor prognosis of colorectal cancer in Taiwan. World J Gastroenterol 2021; 27(34): 5737-5752 [PMID: 34629798 DOI: 10.3748/wjg.v27.i34.5737] [Reference Citation Analysis]
30 Vimalraj S, Saravanan S, Raghunandhakumar S, Anuradha D. Melatonin regulates tumor angiogenesis via miR-424-5p/VEGFA signaling pathway in osteosarcoma. Life Sci 2020;256:118011. [PMID: 32592723 DOI: 10.1016/j.lfs.2020.118011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
31 Ma S, Zhu L, Fan X, Luo T, Liu D, Liang Z, Hu X, Shi T, Tan W, Wang Z. Melatonin derivatives combat with inflammation-related cancer by targeting the Main Culprit STAT3. Eur J Med Chem 2021;211:113027. [PMID: 33248852 DOI: 10.1016/j.ejmech.2020.113027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Li Y, Zou J, Li B, Du J. Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells. J Cell Mol Med 2021;25:9543-56. [PMID: 34547170 DOI: 10.1111/jcmm.16894] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Abdollahzade N, Majidinia M, Babri S. Melatonin: a pleiotropic hormone as a novel potent therapeutic candidate in arsenic toxicity. Mol Biol Rep 2021;48:6603-18. [PMID: 34453671 DOI: 10.1007/s11033-021-06669-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ramos E, López-Muñoz F, Gil-Martín E, Egea J, Álvarez-Merz I, Painuli S, Semwal P, Martins N, Hernández-Guijo JM, Romero A. The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants (Basel) 2021;10:1152. [PMID: 34356384 DOI: 10.3390/antiox10071152] [Cited by in F6Publishing: 1] [Reference Citation Analysis]